Miss Lucinda Hopkins-Jones

2023

• Winchester, L. et al., 2023. Identification of a possible proteomic biomarker in Parkinson’s disease: discovery and replication in blood, brain and cerebrospinal fluid. Brain Communications 5 (1) fcac343. (10.1093/braincomms/fcac343)

2022

• Warne, N. et al. 2022. Collecting genetic samples and linked mental health data from adolescents in schools: protocol co-production and a mixed-methods pilot of feasibility and acceptability. BMJ Open 12 (2) e049283. (10.1136/bmjopen-2021-049283)

2020

• Wong, H. S. et al., 2020. Pilot study to establish a prospective neonatal cohort: Study of Preterm Infants and Neurodevelopmental Genes (SPRING). Molecular Psychiatry 4 (1) e000648. (10.1136/bmjpo-2020-000648)
• Legge, S. et al. 2020. Clinical indicators of treatment-resistant psychosis. British Journal of Psychiatry 216 (5), pp.259-266. (10.1192/bjp.2019.120)

2019

• Harold, D. et al., 2019. Population-based identity-by-descent mapping combined with exome sequencing to detect rare risk variants for schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 180 (3), pp.223-231. (10.1002/ajmg.b.32716)

2017

• Cosgrove, D. et al., 2017. MiR-137-derived polygenic risk: effects on cognitive performance in patients with schizophrenia and controls. Translational Psychiatry 7 (1), pp.e1012. (10.1038/tp.2016.286)